27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
Gainers
- AveXis, Inc. (NASDAQ:AVXS) surged 77.8 percent to $206.07 after the company agreed to be acquired by Novartis AG (NYSE:NVS) for $8.7 billion.
- Turtle Beach Corporation (NASDAQ:HEAR) shares jumped 46.1 percent to $3.74 after the company raised its guidance for the first quarter.
- Therapix Biosciences Ltd. (NASDAQ:TRPX) gained 31.8 percent to $6.5625 after the company disclosed topline results of Phase IIa study at Yale University for Tourette Syndrome program.
- REGENXBIO Inc. (NASDAQ:RGNX) gained 28.7 percent to $35.0095 after dropping 3.89 percent on Friday.
- uniQure N.V. (NASDAQ:QURE) shares gained 18 percent to $25.92.
- Nemaura Medical Inc. (NASDAQ:NMRD) shares jumped 16.3 percent to $3.85. Nemaura Medical named Bashir Timol as Chief Business Officer.
- Aileron Therapeutics, Inc. (NASDAQ:ALRN) shares rose 15.2 percent to $7.335.
- Century Aluminum Company (NASDAQ:CENX) shares surged 13.7 percent to $19.09
- Audentes Therapeutics, Inc. (NASDAQ:BOLD) gained 13.2 percent to $31.805 after dropping 2.87 percent on Friday.
- Abeona Therapeutics Inc. (NASDAQ:ABEO) rose 12.4 percent to $15.74.
- Natera, Inc. (NASDAQ:NTRA) climbed 11.7 percent to $9.8301. Natera named Paul R. Billings, M.D., Ph.D., as Chief Medical Officer. Craig-Hallum initiated coverage on Natera, with a Buy rating.
- Spark Therapeutics, Inc. (NASDAQ:ONCE) climbed 11.6 percent to $69.23.
- Sage Therapeutics, Inc. (NASDAQ:SAGE) shares gained 10.4 percent to $156.02.
- Leucadia National Corporation (NYSE:LUK) climbed 10.3 percent to $24.005 after the company agreed to sell 48 percent of National Beef for $1.05 billion and its stake in Garcadia for $425 million. The company also announced a 25 million share buyback plan.
- Verastem, Inc. (NASDAQ:VSTM) shares climbed 7.9 percent to $3.195 after the company disclosed that the FDA has accepted New Drug Application for duvelisib.
- bluebird bio, Inc. (NASDAQ:BLUE) shares gained 7.1 percent to $174.275 after falling 4.38 percent on Thursday.
- argenx SE (NASDAQ:ARGX) climbed 6.4 percent to $79.64. argenx named Keith Woods as Chief Operating Officer. SunTrust initiated coverage on argenx with a Buy rating.
- Cellect Biotechnology Ltd. (NASDAQ:APOP) gained 5 percent to $6.81. The Israel-based developer of a novel stem cell enabling technology said it has completed a proof of concept testing of its new product prototype called ApoTrainer, which is designed to replace procedures like bone marrow transplants.
- Merck & Co., Inc. (NYSE:MRK) rose 3.4 percent to $55.17 after the company disclosed that its KEYTRUDA monotherapey met its primary endpoint in the Phase 3 KEYNOTE-042 study.
Check out these big penny stock gainers and losers
Losers
- Menlo Therapeutics Inc. (NASDAQ:MNLO) dipped 71.6 percent to $10.00 as the company disclosed that its Phase 2 trial of serlopitant for pruritus associated with atopic dermatitis did not meet primary and key secondary efficacy endpoints.
- ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) shares dropped 21.5 percent to $16.91.
- NMI Holdings, Inc. (NASDAQ:NMIH) shares fell 20.2 percent to $14.12.
- Mechel PAO (NYSE:MTL) shares dipped 18.4 percent to $3.47.
- MGIC Investment Corporation (NYSE:MTG) shares dropped 14.9 percent to $10.91. MGIC Investment is expected to release its Q1 financial results on Wednesday, April 18, 2018.
- Essent Group Ltd. (NASDAQ:ESNT) shares dipped 14.1 percent to $36.15.
- Radian Group Inc. (NYSE:RDN) declined 13.8 percent to $16.50.
- Schmitt Industries, Inc. (NASDAQ:SMIT) fell 11.1 percent to $2.41. Schmitt reported Q3 earnings of $0.00 per share, versus a year-ago loss of $0.04 per share. Its total sales rose 1.2 percent to $3.23 million.
- Twin Disc, Incorporated (NASDAQ:TWIN) shares fell 9.9 percent to $20.49.
- Yandex N.V. (NASDAQ:YNDX) shares fell 9.3 percent to $35.71 after declining 1.84 percent on Friday.
- SSLJ.com Limited (NASDAQ:SSLJ) declined 7.2 percent to $4.825 after dropping 2.80 percent on Friday.
- Marrone Bio Innovations, Inc. (NASDAQ:MBII) shares fell 6.1 percent to $3.0524 after jumping 21.72 percent on Friday.
27% profits every 20 days?
This is what Nic Chahine averages with his options buys. Not selling covered calls or spreads... BUYING options. Most traders don't even have a winning percentage of 27% buying options. He has an 83% win rate. Here's how he does it.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!